Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity
Crossref DOI link: https://doi.org/10.1186/s40164-015-0025-y
Published Online: 2015-10-07
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Yue
Hochster, Howard
Stein, Stacey
Lacy, Jill